NeurogesX Announces Preliminary Results of FDA-Requested Qutenza...(n Rando (media)/Janine McCargo ...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
Date:7/24/2009
n Rando (media)/Janine McCargo (646) 536-7025/7033 jrando@theruthgroup.com jmccargo@theruthgroup.com
'/>"/>
| SOURCE NeurogesX Copyright©2009 PR Newswire. All rights reserved |
Related medicine technology :
1. NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
2. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
3. NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
4. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
5. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
6. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
7. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
8. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
9. Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma
10. Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results
11. Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing
Post Your Comments:
(Date:12/16/2009)... Inc. (OTC Bulletin Board: HEWA) an online U.S. mail-order ... 12% per annum short term debt financing. The ... of $500,000, with accrued interest and principal repayable in ... interest and principal repayable in one year from its ... for any calendar month prior to December 15, 2010. ...
(Date:12/16/2009)... AVAX Technologies, Inc. (Pink Sheets: AVXT) ("AVAX" or ... a bridge loan financing (the "2009 Financing") pursuant ... (the "Agreement") with Firebird Global Master Fund, Ltd., ... a convertible promissory note, due June 30, 2010, ... issued a warrant to purchase an aggregate of ...
(Date:12/16/2009)... Inc. today announced the treatment of the first ... adhesive product, TissuGlu®. Initiation of the study marks ... the lead product toward clinical practice. ,, ... study to investigate the safety of TissuGlu and ... in abdominoplasty, or "tummy tuck," surgeries. The study ...
Breaking Medicine Technology:HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing 2AVAX Technologies, Inc. Closes Bridge Financing 2AVAX Technologies, Inc. Closes Bridge Financing 3AVAX Technologies, Inc. Closes Bridge Financing 4First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 2First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 3Valeritas Announces Appointment of New CEO 12391 1Valeritas Announces Appointment of New CEO 12391 2Valeritas Announces Appointment of New CEO 12391 317 million US children live more than an hour away from trauma care 47486 117 million US children live more than an hour away from trauma care 47486 2Temporary infidelity may contribute to the stability of ancient relationships 8678 1... Cardiovascular, Research Foundation,s ADAPT-DES Study to Quantify Causes and Cures of ... ... Volcano Corporation,(Nasdaq: VOLC ) [TCT Booth #2013 Level 2], a ... its sponsorship of the first major study designed to,examine the role ...
... TUSTIN, Calif., Oct. 22 Peregrine,Pharmaceuticals, Inc. (Nasdaq: ... monoclonal antibodies for the treatment of cancer and,hepatitis ... has submitted a,Phase II clinical protocol with the ... study bavituximab in combination with the chemotherapy drug,docetaxel ...
Other Medicine Technology:Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome 2Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome 3Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome 4Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 2Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 3Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 4Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural OutcomePeregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
(Date:12/16/2009)... Md., Dec. 16 For wounded ... Medical Center in Washington, D.C., the holidays can be ... able to travel home rely more than ever on ... This week, calling home just got easier for ... free calling cards, which will provide hundreds of minutes ...
(Date:12/16/2009)... to disease , , WEDNESDAY, Dec. 16 (HealthDay News) ... leprosy have been identified by scientists in Singapore ... than 10,000 DNA samples from leprosy patients and ... the important role that the innate immune response ... leprosy is not common, the discoveries have significant ...
(Date:12/16/2009)... essential fatty acids commonly found in fatty fish ... to research published by the American Psychological Association. ... problems found in people with schizophrenia; bipolar, obsessive-compulsive, ... afflictions of the nervous system. , The ... , provides more evidence that fish is brain ...
(Date:12/16/2009)... global leader of Digital Pen and Paper technology and the ... trials, today announced that it is ranked among the Fastest ... EMEA 2009. , ... (PRWEB) December ... solutions for the capture, digitalization and management of handwritten data. ...
(Date:12/16/2009)... at all-time low, government report shows, , , WEDNESDAY, Dec. ... United States has reached almost 78 years, a record ... in 2007, women can expect to live to 80.4 ... to the report from the U.S. Centers for Disease ... can expect to live longer than their parents, life ...
Breaking Medicine News(10 mins):Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2Health News:Leprosy Genes Identified 2Health News:New study links DHA type of omega-3 to better nervous-system function 2Health News:With a Revenue Growth of Over 500% During the Last 5 Years, Kayentis is Ranked on the Deloitte Technology Fast 500 -- EMEA 2009 2Health News: Life Expectancy in U.S. Hits New High 2Health News: Life Expectancy in U.S. Hits New High 3[0] Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital[0] Leprosy Genes Identified[0] New study links DHA type of omega-3 to better nervous-system function[0] With a Revenue Growth of Over 500% During the Last 5 Years, Kayentis is Ranked on the Deloitte Technology Fast 500 -- EMEA 2009[0] Life Expectancy in U.S. Hits New High
... Texas is in the process of developing an effective vaccine ... from castor // beans and is considered as the most ... her results from a trial on effective protection obtained from ... of Science. ,The researcher feels still a lot ...
... deterioration among the homeless in New York has surprised ... widespread health examination conducted for the Homeless in the ... the deaths of the Homeless occur with more frequency ... accounting for one-third of the deaths. The report substantiates ...
... A path breaking study by Neuro Scientists has revealed ... stress buster to married women. // According to the ... and touching their husband’s hands, feel immediate relief. A ... situations, even threatening ones! ,A note-worthy feature ...
... medical director of the service NHS 24 has said that there ... in the working of the system. // This was done after ... the NHS 24 service. ,The death of a 17-year-old ... reputation of the NHS 24 help line service. They both had ...
... from cord blood are to be used for regeneration of ... of €2.5 million to be headed by York University and ... involves researchers from department of biology, sociology and Philosophy from ... cord blood stem cells in the treatment of bone defects ...
... at a proposal to cut back on surgery so budget overruns ... at Wagga // Base Hospital, says that the suggestion has officially ... ,"So it'd create a long weekend every four weekends. This would ... great cost to patient care," he said. "It would cause waiting ...
Other Medicine News:Health News:Poor Health of Homeless in New York 2Health News:Handy Touch - A Wand to Bust Stressful Situations 2Health News:NHS 24: A complete makeover 2Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 8 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 17.0 mm and length 21 mm....
The Vitek 2 is a fully automated bacteriology system that performs bacterial identification and susceptibility testing analysis using a standard inoculum. It detects resistance and helps combat bacte...
IDS Rapid Yeast Plus, a microbial identification system....
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |